Technical Analysis for CRVS - Corvus Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 3.56 0.85% 0.03
CRVS closed up 0.85 percent on Friday, September 20, 2019, on 74 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CRVS trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Up 3 Days in a Row Strength 0.00%
Stochastic Reached Oversold Weakness 0.85%
MACD Bearish Signal Line Cross Bearish 4.40%
Narrow Range Bar Range Contraction 4.40%
NR7 Range Contraction 4.40%
Inside Day Range Contraction 4.40%

Older signals for CRVS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies that are designed to harness the immune system to attack cancer cells. Its lead product candidate is CPI-444, an oral, small molecule antagonist of the A2A receptor that plan to initiate a Phase 1/1b clinical trial for adenosine, an immune checkpoint. The company also develops a product candidate, an anti-CD73 monoclonal antibody that inhibits the production of adenosine. Corvus Pharmaceuticals, Inc. was founded in 2014 and is based in Burlingame, California.
Biotechnology Biopharmaceutical Medical Specialties Life Sciences Immunology Immune System Cancer Immunotherapy Monoclonal Antibody Immune Checkpoint Oncology Therapies
Is CRVS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.38
52 Week Low 3.2
Average Volume 150,643
200-Day Moving Average 4.1994
50-Day Moving Average 4.091
20-Day Moving Average 3.623
10-Day Moving Average 3.725
Average True Range 0.3002
ADX 10.95
+DI 21.2362
-DI 22.791
Chandelier Exit (Long, 3 ATRs ) 3.5594
Chandelier Exit (Short, 3 ATRs ) 4.1006
Upper Bollinger Band 4.0752
Lower Bollinger Band 3.1708
Percent B (%b) 0.43
BandWidth 24.962738
MACD Line -0.1114
MACD Signal Line -0.1101
MACD Histogram -0.0013
Fundamentals Value
Market Cap 74.52 Million
Num Shares 20.9 Million
EPS -2.58
Price-to-Earnings (P/E) Ratio -1.38
Price-to-Sales 0.00
Price-to-Book 2.78
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.76
Resistance 3 (R3) 3.76 3.70 3.72
Resistance 2 (R2) 3.70 3.65 3.70 3.71
Resistance 1 (R1) 3.63 3.62 3.67 3.63 3.70
Pivot Point 3.57 3.57 3.59 3.57 3.57
Support 1 (S1) 3.50 3.52 3.54 3.50 3.42
Support 2 (S2) 3.44 3.49 3.44 3.41
Support 3 (S3) 3.37 3.44 3.40
Support 4 (S4) 3.37